Adenovirus
photo of adenovirus
Adenoviruses can cause a spectrum of respiratory disease as well as infection of the stomach and intestine (gastroenteritis), eyes (conjunctivitis), bladder (cystitis) and rash. Adenovirus respiratory diseases include a form of the common cold, pneumonia, croup, and bronchitis. Patients with compromised immune systems are especially susceptible to severe complications of adenovirus infection. Acute respiratory disease (ARD), a disorder first recognized among military recruits during World War II, can be caused by adenovirus infections under conditions of crowding and stress. Adenoviruses are transmitted by direct contact, fecal-oral transmission, and occasionally waterborne transmission. Some types of adenoviruses are capable of establishing persistent asymptomatic infections in the tonsils, adenoids, and intestines. Shedding of the virus can occur for months or years after the initial infection.
This is a 3 module online course (plus quiz) that will provide Military Healthcare Personnel with important and comprehensive information concerning the adenovirus vaccine.
AIG 4905 PDF 26 Jul 11
IMPLEMENTATION OF ADENOVIRUS TYPES 4 AND 7, LIVE, ORAL PROGRAM
ALARACT PDF 21 Jul 11
IMPLEMENTATION OF ADENOVIRUS TYPES 4 AND 7, LIVE, ORAL VACCINE
02 May 12

Sample Q&A: Adenovirus Types 4 and 7 Vaccine

Can the adenovirus vaccine be administered with other vaccines, including live vaccines?
Adenoviruses vaccine types 4 and 7 can be administered simultaneously or at any interval before or after other vaccines, including live vaccines.
Information on DoD Online Adenovirus Vaccine Training
Recommendations of the Armed Forces Epidemiological Board (AFEB)
Recommendations of the Armed Forces Epidemiological Board (AFEB)
Recommendations of the Armed Forces Epidemiological Board (AFEB)
ADENOVIRUS Type 4 and Type 7 LIVE, ORAL VACCINE, ADMINISTRATION COMPETENCY ASSESSMENT Patient Population Served: Recruits (17-50 yrs)
MMQC-11-1660 17 Oct 11
MANUFACTURER WILL BEGIN SHIPMENT OF THE ADENOVIRUS TYPE 4 AND TYPE 7 VACCINE LIVE, ORAL
MMQC-11-1643 03 Oct 11
DELAY IN SHIPMENT OF THE ADENOVIRUS TYPE 4 AND TYPE 7 VACCINE LIVE, ORAL
MMQC-11-1589 01 Sep 11
IMPLEMENTATION GUIDANCE FOR THE ADENOVIRUS TYPE 4 AND TYPE 7 VACCINE LIVE, ORAL
VIS
Vaccine Information Statement